CVS Health (CVS) named Ed DeVaney president of the company’s CVS Caremark pharmacy benefit management business. He was named interim president in December 2024. DeVaney will report to Prem Shah, group president, CVS Health.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- Third Point buys Capital One, cuts Microsoft in Q4
- CVS Health price target raised to $74 from $58 at RBC Capital
- CVS Health price target raised to $70 from $66 at Deutsche Bank
- CVS Health Corp’s Mixed Earnings Call Highlights Growth and Challenges
- CVS Health price target raised to $76 from $60 at Truist